Yahoo
NasdaqGM - Delayed Quote USD

Pharming Group N.V. (PHAR)

12.73 +0.50 (+4.09%)
At close: November 2 at 4:00:00 PM EST
Trade PHAR on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
386,749
376,134
297,200
245,316
205,622
Cost of Revenue
57,687
45,500
35,399
25,212
17,562
Gross Profit
329,062
330,634
261,801
220,104
188,060
Operating Expense
303,313
309,753
265,466
242,393
178,200
Operating Income
25,749
20,881
-3,665
-22,289
9,860
Net Non Operating Interest Income Expense
5,569
-8,739
-5,086
-2,435
-5,378
Other Income Expense
3,010
704
259
12,712
10,505
Pretax Income
34,328
12,847
-8,492
-12,012
14,987
Tax Provision
10,149
10,310
3,349
-1,464
1,313
Net Income Common Stockholders
24,181
2,851
-11,841
-10,548
13,674
Diluted NI Available to Com Stockholders
24,181
2,851
-11,841
-10,548
13,674
Basic EPS
0.35
0.04
-0.16
-0.15
0.21
Diluted EPS
0.33
0.04
-0.16
-0.15
0.19
Basic Average Shares
74,803.03
71,275
68,775
67,460
65,114.29
Diluted Average Shares
84,801.85
71,275
68,775
67,460
71,968.42
Total Operating Income as Reported
32,503
25,842
-8,621
-5,387
18,233
Total Expenses
361,000
355,253
300,865
267,605
195,762
Net Income from Continuing & Discontinued Operation
24,181
2,851
-11,841
-10,548
13,674
Normalized Income
25,233.30
3,959.55
-13,286.42
-21,713.32
3,563.80
Interest Income
3,422
2,176
4,858
3,663
85
Interest Expense
10,309
10,719
8,737
5,964
5,358
Net Interest Income
5,569
-8,739
-5,086
-2,435
-5,378
EBIT
28,434
23,566
245
-6,048
20,345
EBITDA
40,385
34,782
16,315
9,877
33,533
Reconciled Cost of Revenue
57,687
43,493
28,690
18,443
11,528
Reconciled Depreciation
11,951
11,216
16,070
15,925
13,188
Net Income from Continuing Operation Net Minority Interest
24,181
2,851
-11,841
-10,548
13,674
Total Unusual Items Excluding Goodwill
-1,494
-1,494
1,948
12,715
11,081
Total Unusual Items
-1,494
-1,494
1,948
12,715
11,081
Normalized EBITDA
41,879
36,276
14,367
-2,838
22,452
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-441.70
-385.45
502.58
1,549.68
970.80
12/31/2022 - 12/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: